This company listing is no longer active
B5E Stock Overview
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Blackmores Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$56.50 |
| 52 Week High | AU$58.00 |
| 52 Week Low | AU$40.00 |
| Beta | 0.61 |
| 1 Month Change | -0.88% |
| 3 Month Change | 0% |
| 1 Year Change | 3.67% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 24.79% |
Recent News & Updates
Recent updates
Shareholder Returns
| B5E | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.1% | -1.4% |
| 1Y | 3.7% | -0.9% | 2.2% |
Return vs Industry: B5E underperformed the German Personal Products industry which returned 12.3% over the past year.
Return vs Market: B5E exceeded the German Market which returned 1.9% over the past year.
Price Volatility
| B5E volatility | |
|---|---|
| B5E Average Weekly Movement | 1.6% |
| Personal Products Industry Average Movement | 4.8% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: B5E has not had significant price volatility in the past 3 months.
Volatility Over Time: B5E's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1930 | 1,200 | Alastair Symington | www.blackmores.com.au |
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health.
Blackmores Limited Fundamentals Summary
| B5E fundamental statistics | |
|---|---|
| Market cap | €1.10b |
| Earnings (TTM) | €20.63m |
| Revenue (TTM) | €384.42m |
53.2x
P/E Ratio2.9x
P/S RatioIs B5E overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B5E income statement (TTM) | |
|---|---|
| Revenue | AU$645.00m |
| Cost of Revenue | AU$247.11m |
| Gross Profit | AU$397.89m |
| Other Expenses | AU$363.28m |
| Earnings | AU$34.61m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 17, 2023
| Earnings per share (EPS) | 1.78 |
| Gross Margin | 61.69% |
| Net Profit Margin | 5.37% |
| Debt/Equity Ratio | 0% |
How did B5E perform over the long term?
See historical performance and comparison